Literature DB >> 10520229

Regulation of uveal and retinal blood flow in STZ-diabetic and non-diabetic rats; involvement of nitric oxide.

E Granstam1, S O Granstam.   

Abstract

PURPOSE: In experimental and human diabetes mellitus evidence for an impaired function of the vascular endothelial cells has been found. The purpose of the present experiments was to measure uveal and retinal blood flow and vascular resistance at an early stage of experimental diabetes mellitus and to evaluate the effects of acetylcholine and L-arginine in control and L-NAME-pretreated animals.
METHOD: The radioactively labelled microsphere method was applied to normal Sprague-Dawley rats and rats with STZ-induced diabetes of three weeks duration.
RESULTS: In the present study, similar blood flow and vascular resistance were observed in the uvea of normal and STZ-diabetic rats. Evidence for a basal vasodilating NO-tone was found both in the uvea and in the retina of both groups. In the normal rats as well as in the diabetic animals, acetylcholine induced choroidal vasodilation. Local blood flow increased from 54 +/- 17 to 142 +/- 32 mg x min(-1) in normal rats and from 57 +/- 18 to 112 +/- 23 mg x min(-1) in diabetic rats (P < 0.05 respectively). No hemodynamic changes were observed in the anterior uvea, demonstrating a difference in reactivity between these vascular beds. In animals pretreated with the NO-synthase inhibitor L-NAME, acetylcholine did not significantly affect local blood flow in the choroid, suggesting NO as a mediator of the vasodilation.
CONCLUSION: The results indicate a normal action of NO in the ocular vascular beds at this stage of experimental diabetes mellitus in the rat.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10520229     DOI: 10.1076/ceyr.19.4.330.5300

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

1.  Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy.

Authors:  Sarah X Zhang; Jian-Xing Ma; Jing Sima; Ying Chen; Mark S Hu; Anna Ottlecz; George N Lambrou
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

2.  Inner retinal oxygen delivery and metabolism in streptozotocin diabetic rats.

Authors:  Justin Wanek; Pang-Yu Teng; Norman P Blair; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-13       Impact factor: 4.799

3.  Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats.

Authors:  William S Wright; Robert M McElhatten; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2009-12-11       Impact factor: 3.467

4.  Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.

Authors:  William S Wright; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

5.  Ozagrel reverses streptozotocin-induced constriction of arterioles in rat retina.

Authors:  Seungjun Lee; Georgia A Morgan; Norman R Harris
Journal:  Microvasc Res       Date:  2008-07-31       Impact factor: 3.514

6.  Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina.

Authors:  William S Wright; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-01-09       Impact factor: 3.467

7.  Endothelin-induced changes in blood flow in STZ-diabetic and non-diabetic rats: relation to nitric oxide synthase and cyclooxygenase inhibition.

Authors:  Sven-Olof Granstam; Elisabet Granstam
Journal:  J Physiol Sci       Date:  2011-09-01       Impact factor: 2.781

8.  Diabetic mice have retinal and choroidal blood flow deficits and electroretinogram deficits with impaired responses to hypercapnia.

Authors:  Eric R Muir; Divya Narayanan; Saurav B Chandra; Nikolay P Akimov; Jeong-Hyeon Sohn; Evan Meyer; René C Rentería; Timothy Q Duong
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.